Combination of experts and software helps accelerate pediatric drug development and increase clinical trial success rates PRINCETON, NJ – July 29, 2020 – Today, Certara®, the global leader in biosimulation, launches Certara Pediatrics, a new practice area to help biopharmaceutical companies apply model-informed drug development to their pediatric programs and better navigate the changing regulatory landscape. … Continued
Tag: Pediatric oncology
Our speakers will discuss the pediatric oncology regulatory landscape and how modeling and simulation is used in pediatric oncology drug development.
1 of 1